CRME Stock Analysis
CRME - CARDIOME PHARMA CORP listed on NASDAQ.
CRME - Sector: Healthcare, Industry: Biotechnology and Drugs.
CRME gained 2.54% on 07/23/14.
CRME is trading in the range of $6.54 - $8.34 in the past 30 days.
Commodity Channel Index (CCI) is bullish for CRME.
Stock performance base on day of week in the past 90 days.
Our rating on the stock: NEUTRAL with a score of 3/5.